Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.3924 USD
−39.40 M USD
342.00 K USD
7.42 M
About Clene Inc.
Sector
Industry
CEO
Robert Dee Etherington
Website
Headquarters
Salt Lake City
Founded
2013
ISIN
US1856341102
FIGI
BBG00YQ7WGM6
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Displays a symbol's price movements over previous years to identify recurring trends.